Metabolic dysfunction-associated steatohepatitis (MASH) is often referred to as a “silent disease,” as it typically shows no signs of symptoms in early stages. But it can come with certain ...

Josh Ruben, director of the new mash-up between rom-com and slasher movie, tells IndieWire about creating a killer for a new ...

Opens in a new tab or window In patients with severe metabolic dysfunction-associated steatohepatitis (MASH), the investigational drug efruxifermin significantly improved fibrosis without ...

MASH, which was previously known as non–alcohol related steatohepatitis (NASH), is often asymptomatic or leads to nonspecific symptoms, making progression to more severe stages of liver disease ...

If someone’s experiencing symptoms, their MASH tends to be advancing.” For this reason, the first signs of MASH usually show up on routine blood work that you might get during an annual ...

At 10.30am on a chilly Saturday the queue outside Manze’s pie-and-mash shop on Deptford High Street stretches 50 metres down the street. The restaurant has been a fixture of the south-east ...

It's been said that all monster movies fit into at least one of ... leaving audiences to scan every frame for signs of him. Meanwhile, "Wolf Man" works best when its monsters are on-screen ...

Potential competition from GLP-1 drugs and other MASH therapies exists, but REZDIFFRA's combination use and first-mover advantage mitigate these risks. Analysts project $515M in 2025 sales ...

Bunches of Lunches ...

Pepper Lunch, the Japanese-born experiential fast-casual concept unlike any other, with more than 500 locations in 17 countries, today announced it has signed a new development agreement that will ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...